Key references: Approach to managing tuberculosis

  • Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999;3(10 Suppl 2):S231–79. https://www.ncbi.nlm.nih.gov/pubmed/10529902
  • Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2015;(5):CD003343. https://www.ncbi.nlm.nih.gov/pubmed/26022367
  • Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016;63(7):e147–e95. https://www.ncbi.nlm.nih.gov/pubmed/27516382
  • Toms C, Stapledon R, Waring J, Douglas P, National Tuberculosis Advisory Committee ftCDNA, the Australian Mycobacterium Reference Laboratory N. Tuberculosis notifications in Australia, 2012 and 2013. Commun Dis Intell Q Rep 2015;39(2):E217–35. https://www.ncbi.nlm.nih.gov/pubmed/26234258
  • World Health Organization (WHO). Guidelines for treatment of drug-susceptible tuberculosis and patient care: 2017 update. Geneva: WHO; 2017. https://www.who.int/publications/i/item/9789241550000
  • World Health Organization (WHO). WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis. Geneva: WHO; 2018. http://apps.who.int/iris/handle/10665/260494